Reimbursement Scheme FRAGMIN® 2500
The health insurer does not fully reimburse FRAGMIN® 2500. The producer of this medicine has therefore asked TBR Nederland to reimburse the costs of the…
Simplified TerugBetaalRegeling Broxil®
The health insurer will not reimburse the cost of Broxil® 125 mg / 5 mL, powder for oral suspension in full. The producer of this medicine has therefore…
Reimbursement Scheme Forxiga® - Hartfalen
The health insurer does not yet fully reimburse Forxiga® (dapagliflozine) 10 mg for the treatment of symptomatic chronic heart failure with reduced ejection…
TBR Nederland is a unit of Phareso, acronym for PHArmaceutical REimbursement SOlutions. Phareso is an expert provider of state-of-the-art payment solutions. Phareso’s technology is used to…
View all the medicine news
View all the medicine news
View All
If you need any assistance please read our Frequently Asked Questions or contact our Servicedesk on info@tbrnederland.nl…
Reimbursement Scheme Intuniv®
Intuniv’s medicine page has been updated. In the menu 'who can submit a claim' you can now read more about the declaration process of this Reimbursement…
Reimbursement Scheme Elvanse®
Elvanse's medicine page has been updated. In the menu 'who can submit a claim' you can now read more about the declaration process of this Reimbursement…
Claiming for multiple family members
TBR Nederland has added a new function to your account for submitting claims for several people within the same family. This way you no longer have to create…
Launch of TerugBetaalRegeling Broxil®
The health insurer does not fully reimburse Broxil® 125 mg / 5 mL, powder for oral suspension. The producer of this medicine has therefore asked TBR…
